Advanced search
Publication Cover
Journal of Chemotherapy Volume 30, 2018 - Issue 1
Submit an article Journal homepage
189
Views
0
CrossRef citations to date
0
Altmetric
Antimicrobial Original Research Paper

Comparison of antibiotics use, urinary tract infection (UTI)-causative bacteria and their antibiotic susceptibilities among 4 hospitals with different backgrounds and regions in Japan

Katsumi ShigemuraDepartment of Urology, Kobe University Graduate School of Medicine, Kobe, Japan;Infection Control and Prevention, Kobe University Graduate School of Medicine, Kobe, Japan;Division of Infectious Diseases, Department of International Health Science, Kobe University Graduate School of Health Science, Kobe, JapanCorrespondence[email protected]
,
Koichi KitagawaDivision of Translational Research for Biologics, Department of Internal Related, Kobe University Graduate School of Medicine, Kobe, Japan
,
Kayo OsawaInfection Control and Prevention, Kobe University Graduate School of Medicine, Kobe, Japan
,
Fukashi YamamichiDepartment of Urology, Hyogo Prefectural Amagasaki General Medical Center, Amagasaki, Hyogo, Japan
,
Issei TokimatsuInfection Control and Prevention, Kobe University Graduate School of Medicine, Kobe, Japan
,
Masashi NomiInfection control and prevention, Hyogo Prefectural Rehabilitation Central Hospital, Kobe, Japan
,
Kei TakabaInfection control and prevention, Mie Prefectural General Medical Center, Mie, Japan
&
Masato FujisawaDepartment of Urology, Kobe University Graduate School of Medicine, Kobe, Japan
 show all
Pages 31-36 | Published online: 28 Sep 2017

References

  • Foxman B. Epidemiology of urinary tract infections: incidence, morbidity, and economic costs. Am J Med. 2002;113(Suppl 1A):5S–13S.10.1016/S0002-9343(02)01054-9
  • Stamm WE, Hooton TM. Management of urinary tract infections in adults. N Engl J Med. 1993;329:1328–34.
  • Gonzalez CM, Schaeffer AJ. Treatment of urinary tract infection: what’s old, what’s new, and what works. World J Urol. 1999;17:372–82.10.1007/s003450050163
  • Gupta K, Sahm DF, Mayfield D, Stamm WE. Antimicrobial resistance among uropathogens that cause community-acquired urinary tract infections in women: a nationwide analysis. Clin Infect Dis. 2001;33:89–94.10.1086/cid.2001.33.issue-1
  • Sundén F, Wullt B. Predictive value of urinary interleukin-6 for symptomatic urinary tract infections in a nursing home population. Int J Urol. 2016;23:168–74.
  • Lewis DA, Gumede LY, Van der Hoven LA, De Gita GN, De Kock EJ, De Lange T, et al. Antimicrobial susceptibility of organisms causing community-acquired urinary tract infections in Gauteng Province. South Africa. S Afr Med J. 2013;103:377–81.10.7196/SAMJ.6722
  • Hooton TM. Practice guidelines for urinary tract infection in the era of managed care. Int J Antimicrob Agents. 1999;11:241–5.10.1016/S0924-8579(99)00023-0
  • Grabe M, Bartoletti R, Bjerklund-Johansen TE, Cai T, Çek M, Köves B, et al. Guidelines on urological infections infections. Eur Assoc Urol. 2015: pp. 7
  • CLSI. Performance standards for antimicrobial susceptibility testing: 20th informational supplement. CLSI document M100-S19. Wayne (PA): Clinical and Laboratory Standards Institute; 2009.
  • Shigemura K, Arakawa S, Miura T, Nakano Y, Tanaka K, Fujisawa M. Significance of fluoroquinolone-resistant Escherichia coli in urinary tract infections. Jpn J Infect Dis. 2008;61:226–8.
  • Rowe TA, Juthani-Mehta M. Diagnosis and management of urinary tract infection in older adults. Infect Dis Clin North Am. 2014;28:75–89.10.1016/j.idc.2013.10.004
  • Alou L, Aguilar L, Sevillano D, Giménez MJ, Cafini F, Valero E, et al. Urine bactericidal activity against resistant Escherichia coli in an in vitro pharmacodynamic model simulating urine concentrations obtained after 2000/125 mg sustained-release co-amoxiclav and 400 mg norfloxacin administration. J Antimicrob Chemother. 2006;57:714–9.10.1093/jac/dkl041
  • Akram M, Shahid M, Khan AU. Etiology and antibiotic resistance patterns of community-acquired urinary tract infections in J N M C Hospital Aligarh. India. Ann Clin Microbiol Antimicrob. 2007;6:4.10.1186/1476-0711-6-4
  • Doernberg SB, Dudas V, Trivedi KK. Implementation of an antimicrobial stewardship program targeting residents with urinary tract infections in three community long-term care facilities: a quasi-experimental study using time-series analysis. Antimicrob Resist Infect Control. 2015;4:54.10.1186/s13756-015-0095-y
  • Eom JS, Hwang BY, Sohn JW, Kim WJ, Kim MJ, Park SC, et al. Clinical and molecular epidemiology of quinolone-resistant Escherichia coli isolated from urinary tract infection. Microb Drug Resist. 2002;8:227–34.10.1089/107662902760326959
  • Colodner R, Kometiani I, Chazan B, Raz R. Risk Factors for community-acquired urinary tract infection due to quinolone-resistant E. coli. Infection. 2008;36:41–5.10.1007/s15010-007-7083-y
  • Perfetto EM, Keating K, Merchant S, Nichols BR. Acute uncomplicated UTI and E. coli resistance: implications for first-line empirical antibiotic therapy. J Manag Care Pharm. 2004;10:17–25.
  • Cohen-Nahum K, Saidel-Odes L, Riesenberg K, Schlaeffer F, Borer A. Urinary tract infections caused by multi-drug resistant Proteus mirabilis: risk factors and clinical outcomes. Infection. 2010;38:4–6.
  • Kothari A, Sagar V. Antibiotic resistance in pathogens causing community-acquired urinary tract infections in India: a multicenter study. J Infect Dev Ctries. 2008;2:354–8.
  • Rubin RH, Fang LS, Jones SR, Munford RS, Slepack JM, Varga PA, et al. Single-dose amoxicillin therapy for urinary tract infection: multicenter trial using antibody-coated bacteria localization technique. JAMA. 1980;244:561–4.10.1001/jama.1980.03310060017014
  • Hamasuna R, Tanaka K, Hayami H, Yasuda M, Takahashi S, Kobayashi K, et al. Treatment of acute uncomplicated cystitis with faropenem for 3 days versus 7 days: multicentre, randomized, open-label, controlled trial. J Antimicrob Chemother. 2014;69:1675–80.10.1093/jac/dku014
  • Gavazzi G, Delerce E, Cambau E, François P, Corroyer B, de Wazières B, et al. Diagnostic criteria for urinary tract infection in hospitalized elderly patients over 75 years of age: a multicenter cross-sectional study. Med Mal Infect. 2013;43:189–94.10.1016/j.medmal.2013.02.006

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Order Reprints Request Corporate Permissions

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

Request Academic Permissions

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.

Related research

People also read lists articles that other readers of this article have read.

Recommended articles lists articles that we recommend and is powered by our AI driven recommendation engine.

Cited by lists all citing articles based on Crossref citations.
Articles with the Crossref icon will open in a new tab.